REVVITY INC (RVTY)

US7140461093 - Common Stock

112.56  +2.02 (+1.83%)

After market: 112.56 0 (0%)

Fundamental Rating

5

Overall RVTY gets a fundamental rating of 5 out of 10. We evaluated RVTY against 57 industry peers in the Life Sciences Tools & Services industry. While RVTY has a great profitability rating, there are some minor concerns on its financial health. RVTY has a valuation in line with the averages, but it does not seem to be growing.



7

1. Profitability

1.1 Basic Checks

RVTY had positive earnings in the past year.
RVTY had a positive operating cash flow in the past year.
In the past 5 years RVTY has always been profitable.
Each year in the past 5 years RVTY had a positive operating cash flow.

1.2 Ratios

RVTY's Return On Assets of 1.99% is fine compared to the rest of the industry. RVTY outperforms 69.64% of its industry peers.
RVTY has a Return On Equity of 3.21%. This is in the better half of the industry: RVTY outperforms 71.43% of its industry peers.
RVTY has a better Return On Invested Capital (2.77%) than 67.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RVTY is below the industry average of 9.66%.
Industry RankSector Rank
ROA 1.99%
ROE 3.21%
ROIC 2.77%
ROA(3y)5.14%
ROA(5y)5.61%
ROE(3y)9.91%
ROE(5y)11.46%
ROIC(3y)5.67%
ROIC(5y)7.44%

1.3 Margins

RVTY's Profit Margin of 9.34% is amongst the best of the industry. RVTY outperforms 80.36% of its industry peers.
In the last couple of years the Profit Margin of RVTY has grown nicely.
RVTY's Operating Margin of 13.92% is fine compared to the rest of the industry. RVTY outperforms 76.79% of its industry peers.
RVTY's Operating Margin has improved in the last couple of years.
RVTY has a better Gross Margin (55.44%) than 73.21% of its industry peers.
RVTY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.92%
PM (TTM) 9.34%
GM 55.44%
OM growth 3Y-18.34%
OM growth 5Y3.77%
PM growth 3Y9.4%
PM growth 5Y24.09%
GM growth 3Y0.12%
GM growth 5Y3.01%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RVTY is destroying value.
Compared to 1 year ago, RVTY has less shares outstanding
The number of shares outstanding for RVTY has been increased compared to 5 years ago.
RVTY has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.80 indicates that RVTY is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.80, RVTY is doing good in the industry, outperforming 60.71% of the companies in the same industry.
The Debt to FCF ratio of RVTY is 5.65, which is a neutral value as it means it would take RVTY, 5.65 years of fcf income to pay off all of its debts.
RVTY's Debt to FCF ratio of 5.65 is fine compared to the rest of the industry. RVTY outperforms 66.07% of its industry peers.
RVTY has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, RVTY perfoms like the industry average, outperforming 44.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.65
Altman-Z 2.8
ROIC/WACC0.25
WACC10.97%

2.3 Liquidity

RVTY has a Current Ratio of 3.56. This indicates that RVTY is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.56, RVTY is doing good in the industry, outperforming 62.50% of the companies in the same industry.
RVTY has a Quick Ratio of 2.97. This indicates that RVTY is financially healthy and has no problem in meeting its short term obligations.
RVTY has a Quick ratio (2.97) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 2.97

3

3. Growth

3.1 Past

RVTY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.25%.
Measured over the past 5 years, RVTY shows a small growth in Earnings Per Share. The EPS has been growing by 5.14% on average per year.
The Revenue has decreased by -2.66% in the past year.
RVTY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.20% yearly.
EPS 1Y (TTM)-7.25%
EPS 3Y-17.53%
EPS 5Y5.14%
EPS Q2Q%8.47%
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y-10.08%
Revenue growth 5Y-0.2%
Sales Q2Q%1.98%

3.2 Future

RVTY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.43% yearly.
Based on estimates for the next years, RVTY will show a small growth in Revenue. The Revenue will grow by 5.03% on average per year.
EPS Next Y6.35%
EPS Next 2Y5.87%
EPS Next 3Y7.92%
EPS Next 5Y10.43%
Revenue Next Year0.93%
Revenue Next 2Y3.04%
Revenue Next 3Y4.28%
Revenue Next 5Y5.03%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

5

4. Valuation

4.1 Price/Earnings Ratio

RVTY is valuated rather expensively with a Price/Earnings ratio of 23.80.
RVTY's Price/Earnings ratio is rather cheap when compared to the industry. RVTY is cheaper than 85.71% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.20, RVTY is valued at the same level.
Based on the Price/Forward Earnings ratio of 21.60, the valuation of RVTY can be described as rather expensive.
Based on the Price/Forward Earnings ratio, RVTY is valued cheaper than 82.14% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of RVTY to the average of the S&P500 Index (23.73), we can say RVTY is valued inline with the index average.
Industry RankSector Rank
PE 23.8
Fwd PE 21.6

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RVTY is valued cheaper than 89.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, RVTY is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 24.27
EV/EBITDA 19.4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RVTY does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of RVTY may justify a higher PE ratio.
PEG (NY)3.75
PEG (5Y)4.63
EPS Next 2Y5.87%
EPS Next 3Y7.92%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.25%, RVTY is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.66, RVTY pays a better dividend. On top of this RVTY pays more dividend than 83.93% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, RVTY's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.25%

5.2 History

The dividend of RVTY decreases each year by -0.06%.
RVTY has paid a dividend for at least 10 years, which is a reliable track record.
RVTY has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.06%
Div Incr Years0
Div Non Decr Years23

5.3 Sustainability

13.59% of the earnings are spent on dividend by RVTY. This is a low number and sustainable payout ratio.
DP13.59%
EPS Next 2Y5.87%
EPS Next 3Y7.92%

REVVITY INC

NYSE:RVTY (12/20/2024, 8:04:01 PM)

After market: 112.56 0 (0%)

112.56

+2.02 (+1.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04 2024-11-04/bmo
Earnings (Next)01-30 2025-01-30/amc
Inst Owners90.94%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner Change-2.91%
Market Cap13.70B
Analysts77.04
Price Target141.73 (25.92%)
Short Float %3.55%
Short Ratio4.7
Dividend
Industry RankSector Rank
Dividend Yield 0.25%
Dividend Growth(5Y)-0.06%
DP13.59%
Div Incr Years0
Div Non Decr Years23
Ex-Date01-17 2025-01-17 (0.07)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.04%
Min EPS beat(2)6.64%
Max EPS beat(2)11.44%
EPS beat(4)4
Avg EPS beat(4)6.6%
Min EPS beat(4)2.99%
Max EPS beat(4)11.44%
EPS beat(8)6
Avg EPS beat(8)2.4%
EPS beat(12)10
Avg EPS beat(12)5.08%
EPS beat(16)14
Avg EPS beat(16)9.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-1.74%
Max Revenue beat(2)-1.33%
Revenue beat(4)1
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.74%
Max Revenue beat(4)0.64%
Revenue beat(8)1
Avg Revenue beat(8)-6.61%
Revenue beat(12)3
Avg Revenue beat(12)-4.06%
Revenue beat(16)7
Avg Revenue beat(16)-1.09%
PT rev (1m)-0.56%
PT rev (3m)1.97%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)-1.39%
EPS NY rev (1m)0.07%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-2.47%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 23.8
Fwd PE 21.6
P/S 5.03
P/FCF 24.27
P/OCF 21.05
P/B 1.73
P/tB N/A
EV/EBITDA 19.4
EPS(TTM)4.73
EY4.2%
EPS(NY)5.21
Fwd EY4.63%
FCF(TTM)4.64
FCFY4.12%
OCF(TTM)5.35
OCFY4.75%
SpS22.36
BVpS65.09
TBVpS-11.51
PEG (NY)3.75
PEG (5Y)4.63
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 3.21%
ROCE 3.13%
ROIC 2.77%
ROICexc 3.08%
ROICexgc 21.88%
OM 13.92%
PM (TTM) 9.34%
GM 55.44%
FCFM 20.74%
ROA(3y)5.14%
ROA(5y)5.61%
ROE(3y)9.91%
ROE(5y)11.46%
ROIC(3y)5.67%
ROIC(5y)7.44%
ROICexc(3y)6.02%
ROICexc(5y)7.89%
ROICexgc(3y)45.83%
ROICexgc(5y)49.71%
ROCE(3y)6.41%
ROCE(5y)8.42%
ROICexcg growth 3Y-23.19%
ROICexcg growth 5Y2.08%
ROICexc growth 3Y-39.41%
ROICexc growth 5Y-10.59%
OM growth 3Y-18.34%
OM growth 5Y3.77%
PM growth 3Y9.4%
PM growth 5Y24.09%
GM growth 3Y0.12%
GM growth 5Y3.01%
F-Score6
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 5.65
Debt/EBITDA 3.95
Cap/Depr 20.15%
Cap/Sales 3.17%
Interest Coverage 250
Cash Conversion 80.62%
Profit Quality 221.93%
Current Ratio 3.56
Quick Ratio 2.97
Altman-Z 2.8
F-Score6
WACC10.97%
ROIC/WACC0.25
Cap/Depr(3y)22.27%
Cap/Depr(5y)27.25%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.6%
Profit Quality(3y)81.6%
Profit Quality(5y)96.14%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.25%
EPS 3Y-17.53%
EPS 5Y5.14%
EPS Q2Q%8.47%
EPS Next Y6.35%
EPS Next 2Y5.87%
EPS Next 3Y7.92%
EPS Next 5Y10.43%
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y-10.08%
Revenue growth 5Y-0.2%
Sales Q2Q%1.98%
Revenue Next Year0.93%
Revenue Next 2Y3.04%
Revenue Next 3Y4.28%
Revenue Next 5Y5.03%
EBIT growth 1Y-12.98%
EBIT growth 3Y-26.57%
EBIT growth 5Y3.57%
EBIT Next Year14.81%
EBIT Next 3Y10.52%
EBIT Next 5Y13.37%
FCF growth 1Y-28.04%
FCF growth 3Y-77.01%
FCF growth 5Y-46.1%
OCF growth 1Y-25.74%
OCF growth 3Y-53.23%
OCF growth 5Y-21.74%